Products

What will AGI do for Benproperine?

This classification denotes an antitussive agent with the molecular formula C21H27NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 3AA6IZ48YK, chemically known as piperidine, 1-(1-methyl-2-((alpha-phenyl-o-tolyl)oxy)ethyl)- but more generally known as benproperine, which bears US NIH Compound Identifier 2326. Benproperine most often comes in basem, embonate, pamoate, phosphate, and trihydrogen phosphate forms. European Medicines Agency schedules Benproperine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05728MIG. The term BENPROPERINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules benproperine in its Anatomical Therapeutic Chemical (ATC) Classification. BENPROPERINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule benproperine under HS 29333999 and SITC 51574. As of Q4 2014, BENPROPERINE remains US FDA's Preferred Term for this commodity. Benproperine bears US NLM identifiers UMLS ID C0772056 and NCI Concept Code C78103. SMILES: O(CC(N1CCCCC1)C)C1C(CC2CCCCC2)CCCC1.